Physician profile
Analice S Hoffenberg
NPI 1568673606
$991.49
in general payments reported to CMS, 2019-2025
12 companies · $365 in 2025
The $365 reported for 2025 was more than what 76% of Public Health & General Preventive Medicine providers received nationally (typical 2025 total: $95.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2023: $197 · 2024: $309 · 2025: $365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $871.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $871.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $405.44 | 2023-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $275.88 | 2024-2025 | Caplyta |
| Alkermes, INC. | $72.74 | 2025 | Aristada, Lybalvi, Vivitrol |
| Orexo US, INC. | $58.82 | 2019 | |
| Indivior INC. | $34.31 | 2019-2024 | Sublocade |
| Supernus Pharmaceuticals, INC. | $33.27 | 2025 | Qelbree |
| Teva Pharmaceuticals USA, INC. | $23.89 | 2023 | Austedo Xr |
| Braeburn INC. | $23.86 | 2025 | Brixadi |
| Vanda Pharmaceuticals INC. | $22.53 | 2025 | Fanapt |
| Biodelivery Sciences International, INC. | $17.78 | 2019 | |
| Collegium Pharmaceutical, INC. | $12.15 | 2019 | |
| Mdd US Operations, LLC | $10.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Analice Hoffenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.